Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00614744 · ClinicalTrials.gov registry record · NA
Late Hypothermia for Hypoxic-Ischemic Encephalopathy
A NA study, sponsored by NICHD Neonatal Research Network.
- Completed
- Registry status
- NA
- Development phase
- 168
- Enrollment target
NCT00614744 is a NA study that has completed, run by NICHD Neonatal Research Network. The registered enrollment target is 168 participants.
The verdict
NCT00614744, a NA study, has completed, sponsored by NICHD Neonatal Research Network.
- COMPLETED
- Registry status
- NA
- Development phase
- 168 participants
- Enrollment target
Study Summary
This study is a randomized, placebo-controlled, clinical trial to evaluate whether induced whole-body hypothermia initiated between 6-24 hours of age and continued for 96 hours in infants ≥ 36 weeks gestational age with hypoxic-ischemic encephalopathy will reduce the incidence of death or disability at 18-22 months of age. The study will enroll 168 infants with signs of hypoxic-ischemic encephalopathy at 16 NICHD Neonatal Research Network sites, and randomly assign them to either receive hypothermia or participate in a non-cooled control group.
Interventions
- PROCEDURE Normothermic Control
- PROCEDURE Hypothermia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2008-04 |
| Est. Completion | 2016-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00614744
The ClinicalTrials.gov registry entry for NCT00614744 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NICHD Neonatal Research Network, which has 61 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Normothermic Control is the first listed.
NCT00614744 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00614744 about?
NCT00614744 is a clinical study titled "Late Hypothermia for Hypoxic-Ischemic Encephalopathy". This study is a randomized, placebo-controlled, clinical trial to evaluate whether induced whole-body hypothermia initiated between 6-24 hours of age and continued for 96 hours in infants ≥ 36 weeks gestational age with hypoxic-ischemic encephalopathy will reduce the incidence of death or disability...
What is the current status of trial NCT00614744?
This trial is currently completed. It is a NA study. The enrollment target is 168 participants. The study started on 2008-04. Estimated completion is 2016-06.
What interventions are being tested in trial NCT00614744?
The interventions under investigation include: Normothermic Control (PROCEDURE), Hypothermia (PROCEDURE).
Who is sponsoring clinical trial NCT00614744?
This trial is sponsored by NICHD Neonatal Research Network, which has 61 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.